Hunchuck, Jonathan E <br/><br/>
Dabigatran for stroke prevention in all patients with atrial fibrillation?  [electronic resource] 

 -  Pharmacotherapy  Aug 2011 
 - 725-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Editorial 
<br/><br/><label>ISSN: </label>1875-9114 
<br/><br/><label>Standard No.: </label>10.1592/phco.31.8.725  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anticoagulants--adverse effects<br/>Atrial Fibrillation--complications<br/>Benzimidazoles--adverse effects<br/>Dabigatran<br/>Drug Monitoring--methods<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Stroke--etiology<br/>Warfarin--adverse effects<br/>beta-Alanine--adverse effects